BPC 157 No Proof Required! Office for Science and Society McGill University The peptide problem: Hype is outrunning the evidence BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Think twice before injecting peptides bought online: unauthorized products can seriously harm you Canada.ca BPC 157: Experimental Peptide Creates Risk for Athletes